References
- Chao E. S., Dunbar D., Kaminsky L. S. lntracellular lactate dehydrogenase concentration as an index of cytotoxicity in rat hepatocyte primary culture. Cell Biology and Toxicology 1988; 4: 1–11
- Cribb A. E., Mller M., Leeder J. S., Hill J., Spielberg S. P. Reactions of the nitroso andhydroxylamine metabolites of sulphamethoxazole with reduced glutathione. Drug Metabolism andDisposition 1991a; 19: 900–906
- Cribb A. E., Grant D. M., Miller M., Spielberg S. P. Expression of monomorphic arylamine N-acetyltransferase (NATI) in human leukocytes. Journal of Pharmacology and Experimental Therapeutics 1991b; 251: 1241–1247
- Cribb A. E., Nakamura H., Grant D. M., Miller M. A., Spielberg S. P. Role of polymorphic andmonomorphic human arylamine N-acetyltransferases in determining suphamethoxazole metabolism. Biochemica, Pharmacology 1992; 45: 1277–122
- Cribb A. E., Lee B. L., Trepanier L. A., Spielberg S. P. a). Adverse reactions to sulphonamide andsulphonamidetrimethoprim antimicrobials: clinical syndromes andpathogenesis. Adverse Drug Reactions and Toxicological Reviews 1996; 15: 9–50
- Cribb A. E., Nuss C. E., Alberts D. W., Lamphere D. B., Grant D. M., Grossman S. J., Spielberg S. P. Covalent binding of sulphamethoxazole reactive metabolites to human andrat liver subcellular fractions assessed by immunochemical detection. Chemical Research in Toxicology 1996b; 9: 500–507
- Dupret J. M., Grant D. M. Sitedirected mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia coli. Journal of Biological Chemistry 1992; 267: 7381–7385
- Kearns G. L., Wheeler J. G., Childdress S. H., Letzig L. G. Serum sickness-like reactions to cefaclor—role of hepaticmetabolism andindividual susceptibility. Journal of Pediatrics 1994; 125: 805–811
- Lee B. L., Delahunty T., Safrin S. The hydroxylamine of sulphamethoxazole andadverse reactions in patients with acquired immunodeficiency syndrome. Clinical Pharmacology and Therapeutics 1994; 56: 184–189
- Nakamura H., Cribb A. E., Utrecht J., Nasser Z., Miller M., Grant D. M., Spielberg S. P. Metabolism andtoxicity of N-acetoxysulphamethoxazole: a potential candidate for the ultimate toxin in sulphonamide hypersensitivity reactions. Journal of Pharmacology and Experimental Therapeutics 1995; 274: 1099–1104
- Ponsoda X., Rover J., Castell J. V., Gonez-Lechon M. J. Measurement of intracellular LDH actnrity in 96-well cultures: a rapid andautomated assay for cytotoxicity studies. Journal of Tissue Culture Methods 1991; 13: 21–24
- Rieder M. J., Uetrecht J., Shear N. H., Cannon M., Miller M., Spielberg S. P. Diagnosis of sulphonamide hypersensitivity reactions by in vitro ‘rechallenge’ with hydroxylamine metabolites. Annals of Internal Medicine 1989; 110: 286–289
- Rieder M. J., Shear N. H., Kanee A., Tang B. K., Spielberg S. P. Prominence of slow acetylator phenotype among patients with sulphonamide hypersensitivity reactions. Clinical Pharmacology andTherapeutics 1991; 49: 13–17
- Riley R. J., Cribb A. E., Spielberg S. P. Glutathione transferase μ deficiency is not a marker for predisposition to sulphonamide toxicity. Biochemical Pharmacology 1991; 42: 696–698
- Shear N. H., Spielberg S. P. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. Journal of Clinical Investigation 1988; 82: 1826–1832
- Shear N. H., Spielberg S. P., Grant D. M., Tang B. K., Kalow W. Differences in metabolism of sulphonamides predisposing to idiosyncratic toxicity. Annals of Internal Medicine 1986; 105: 179–84
- van der Ven A. J.A.M., Vree T. B., Kolmer E. W.J.V., Koppmans P.P., van Der Meer J. W. M. Urinary recovery andkinetics of sulphamethoxazole andits metabolites in HIV-seropositive patients andhealty volunteers after a single oral dose of sulphamethoxazole. British Journal of Clinical Pharmacology 1995; 38: 147–150
- Wolkenstein P., Carriere V., Charue D., Bastujigarin S., Revuz J., Roujeau J. C. A slow acetylator phenotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis andStevens-Johnson syndrome. Pharmacogenetics 1995; 5: 255–258